Diligence · Specialty Distribution

Independent Sponsor Regulatory Diligence in Specialty Distribution

When the deal is specialty distribution and the question is Regulatory Diligence, the structure decisions in the first 30 days outlast the next five years. This is where Jason Powell works.

EV range $10M to $100M EV EBITDA $2.5M to $18M Audience Buy-side / Sponsor
The deal context

Specialty Distribution deals in the lower middle market run a specific playbook. Regulatory Diligence is where the structure either holds or starts to leak.

The typical specialty distribution platform sits at $10M to $100M EV with EBITDA in the $2.5M to $18M range. The thesis runs on vertical buy-up of niche product distributors. Most distribution multiples are wrong by half a turn until the rebate accounting gets normalized.

The moves

How Regulatory Diligence actually gets structured.

  1. Map every license and permit, with renewal dates and transfer mechanics.

  2. Identify regulatory consent requirements that require pre-close filings.

  3. Address pending or threatened regulatory actions in the disclosure schedules.

  4. Plan the post-close regulatory calendar with the operating team.

  5. In specialty distribution, layer in supplier reaffirmation letters before LOI signs as part of the Regulatory Diligence workstream.

The common mistake

Treating regulatory diligence as a sub-section. In regulated industries, it is the whole deal.

Jason's take
"Regulatory continuity is the closing condition that fails most often. Diligence it first, not last."
Jason Powell · Regulatory Diligence
Capital after close

The deal is one thing. The capital that opens up after close is another.

Most independent sponsors solve the closing capital and then run into the post-close capital problem alone. The capital markets relationships that matter at month 18 are part of this practice.

MONTH 18
Senior refi
MONTH 24
Dividend recap
MONTH 36
Growth equity
YEAR 4–5
Strategic exit
TALK TO JASON

An LOI on the desk, a specialty distribution target, and a Regulatory Diligence question worth a real conversation.

Twenty minutes of practitioner-grade input from a securities attorney whose first move is to read the deal, not the engagement letter.